Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 EUR | -62.50% | -62.50% | +500.00% |
2023 | Gour Medical SA announced that it has received â¬0.135 million in funding | CI |
2023 | Gour Medical SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2021 | 0 0 0 | Sales 2022 | 0 0 0 | Capitalization | 133K 124K 182K |
---|---|---|---|---|---|
Net income 2021 | - 0 0 | Net income 2022 | - 0 0 | EV / Sales 2021 | 1,196,860,759 x |
Net Debt 2021 | 814K 756K 1.11M | Net Debt 2022 | 23.49K 21.82K 32.15K | EV / Sales 2022 | 156,521,000,000 x |
P/E ratio 2021 |
-1.38
x | P/E ratio 2022 |
-9.55
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1 day | -62.50% | ||
1 week | -62.50% | ||
Current month | -62.50% | ||
1 month | -57.14% | ||
3 months | -57.14% | ||
6 months | +50.00% | ||
Current year | +500.00% |
Managers | Title | Age | Since |
---|---|---|---|
Serge Goldner
CEO | Chief Executive Officer | 59 | 14-07-13 |
Eva Bleul
LAW | General Counsel | - | - |
Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Avenard
BRD | Director/Board Member | - | 19-02-28 |
Director/Board Member | 65 | - | |
Serge Goldner
CEO | Chief Executive Officer | 59 | 14-07-13 |
Date | Price | Change |
---|---|---|
24-05-03 | 0.03 | -62.50% |
24-05-02 | 0.08 | 0.00% |
24-04-30 | 0.08 | 0.00% |
24-04-29 | 0.08 | 0.00% |
Real-time Euronext Paris, May 03, 2024 at 05:30 am
More quotes- Stock Market
- Equities
- MLCOT Stock